Oligonucleotide-Based Mimetics of Hepatocyte Growth Factor.

Oligonucleotide-based hepatocyte growth factor (HGF) mimetics are described. A DNA aptamer to Met, a cognate receptor for HGF, was shown to induce Met activation when used in dimer form. The most potent aptamer dimer, ss-0, which was composed solely of 100-mer single-stranded DNA, exhibited nanomolar potency. Aptamer ss-0 reproduced HGF-induced cellular behaviors, including migration and proliferation. The present work sheds light on oligonucleotides as a novel chemical entity for the design of growth factor mimetics.

[1]  B. Sullenger,et al.  Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer. , 2008, Chemistry & biology.

[2]  P. Comoglio,et al.  Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF. , 1998, Journal of cell science.

[3]  J. Schlessinger,et al.  Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.

[4]  O. Chaloin,et al.  DNA-templated homo- and heterodimerization of peptide nucleic acid encoded oligosaccharides that mimick the carbohydrate epitope of HIV. , 2009, Angewandte Chemie.

[5]  L. Trusolino,et al.  MET signalling: principles and functions in development, organ regeneration and cancer , 2010, Nature Reviews Molecular Cell Biology.

[6]  John C Chaput,et al.  Creating protein affinity reagents by combining peptide ligands on synthetic DNA scaffolds. , 2009, Journal of the American Chemical Society.

[7]  T. Natsume,et al.  Artificial human Met agonists based on macrocycle scaffolds , 2015, Nature Communications.

[8]  Giulio Cossu,et al.  Magic-Factor 1, a Partial Agonist of Met, Induces Muscle Hypertrophy by Protecting Myogenic Progenitors from Apoptosis , 2008, PloS one.

[9]  T L Blundell,et al.  Crystal structures of NK1–heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor , 2001, The EMBO journal.

[10]  Steven M. Moss,et al.  Programmable Nanoscaffolds That Control Ligand Display to a G-Protein-Coupled Receptor in Membranes To Allow Dissection of Multivalent Effects , 2014, Journal of the American Chemical Society.

[11]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[12]  R. Haag,et al.  DNA‐gesteuerte bivalente Präsentation von Liganden für den Östrogenrezeptor , 2011 .

[13]  G. V. Vande Woude,et al.  Structural basis for agonism and antagonism of hepatocyte growth factor , 2010, Proceedings of the National Academy of Sciences.

[14]  G. V. Vande Woude,et al.  A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist , 2007, Proceedings of the National Academy of Sciences.

[15]  E. Gilboa,et al.  CD28 Aptamers as Powerful Immune Response Modulators , 2013, Molecular therapy. Nucleic acids.

[16]  S. Bhatia,et al.  Pluripotent stem cell-derived hepatocyte-like cells. , 2014, Biotechnology advances.

[17]  O. Seitz,et al.  DNA as a molecular ruler: interrogation of a tandem SH2 domain with self-assembled, bivalent DNA-peptide complexes. , 2011, Angewandte Chemie.

[18]  J. Cochran,et al.  An engineered dimeric fragment of hepatocyte growth factor is a potent c‐MET agonist , 2014, FEBS letters.

[19]  Harald Kolmar,et al.  Bi-specific Aptamers Mediating Tumor Cell Lysis , 2011, The Journal of Biological Chemistry.

[20]  R. Ueki,et al.  A DNA aptamer to c-Met inhibits cancer cell migration. , 2014, Chemical communications.

[21]  D. Margulies,et al.  Targeted protein surface sensors as a tool for analyzing small populations of proteins in biological mixtures. , 2014, Angewandte Chemie.

[22]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[23]  Kunio Matsumoto,et al.  HGF–Met Pathway in Regeneration and Drug Discovery , 2014, Biomedicines.

[24]  Marcus Weber,et al.  DNA-controlled bivalent presentation of ligands for the estrogen receptor. , 2011, Angewandte Chemie.

[25]  J. Cochran,et al.  Engineering hepatocyte growth factor fragments with high stability and activity as Met receptor agonists and antagonists , 2011, Proceedings of the National Academy of Sciences.

[26]  C. Wells,et al.  HGF-induced DU145 cell scatter assay. , 2011, Methods in molecular biology.

[27]  Chan Hyuk Kim,et al.  Self-assembled antibody multimers through peptide nucleic acid conjugation. , 2013, Journal of the American Chemical Society.

[28]  G. Church,et al.  Large-scale de novo DNA synthesis: technologies and applications , 2014, Nature Methods.

[29]  J. McNamara,et al.  Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice. , 2008, The Journal of clinical investigation.

[30]  H. Niemann.  Structural insights into Met receptor activation. , 2011, European journal of cell biology.

[31]  W. Birchmeier,et al.  Met, metastasis, motility and more , 2003, Nature Reviews Molecular Cell Biology.